Skip to Main Content

SPS PGD template for supply of flucloxacillin for infected insect bites or stings.

Provenance

SPS national PGD templates for antimicrobials created by SPS with support from the Royal College of General Practitioners (RCGP), the Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infection (ARPHAI), UK Health Security Agency (UKHSA) and NHS England (NHSE) with the support of specialist stakeholders working within clinical practice.

Published versions

Version 2.0 of this PGD template, valid from March 2027, has been published to allow organisations to undertake local governance processes in a timely manner.

Version 1.1 of this PGD template remains currently valid and will be removed from this page on its expiry (28thFebruary 2027).

PGD template attachment

The template PGD is attached below to download and use in conjunction with our implementation advice (SPS page).

More antimicrobial PGDs

Exploring real-world prescribing through expert insights, practical tools, and lived experiences to support prescribers in developing safe, confident practice.
Commissioning, implementation and impact of a neighbourhood warfarin clinic developed via the Community Pharmacy Independent Prescribing Pathfinder Programme
An SPS Quality Assurance (QA) bite size learning event on capacity management in pharmacy aseptic services.
Find information on Adcomfo and Omlyclo biosimilars, including indications, formulations, supporting evidence and differences.
Find information to support planning, implementation and use of omalizumab biosimilars in NHS services.
Legislation and regulation governing the waste management of controlled drugs (CDs).
Classification of sharps contaminated with pharmaceutical waste and guidance on the appropriate disposal containers to use.
Guidance on which medications to use when treating CRS and ICANS.
Guidance on the management of immune effector cell-associated neurotoxicity syndrome (ICANS) in adults receiving licensed CAR-T cell products.
Guidance on the management of CRS in adult patients receiving licensed CAR-T cell products.

All PGD templates

National PGD, protocol and written instructions templates

National templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.

Update history

  1. Republished
  2. PGD template V2.0 published
  1. V1.1 PGD template replaced with accessible version
  1. PGD template V1.0 replaced with V1.1
  1. Published